Inspire Medical Systems, Inc. (FRA:2DR)

Inspire Medical Systems Statistics

Total Valuation

FRA:2DR has a market cap or net worth of EUR 3.12 billion. The enterprise value is 2.87 billion.

Market Cap	3.12B
Enterprise Value	2.87B

Important Dates

The next estimated earnings date is Wednesday, January 7, 2026.

Earnings Date	Jan 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	29.06M
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	102.35%
Float	25.36M

Valuation Ratios

The trailing PE ratio is 82.09 and the forward PE ratio is 75.65.

PE Ratio	82.09
Forward PE	75.65
PS Ratio	4.14
PB Ratio	5.49
P/TBV Ratio	5.49
P/FCF Ratio	37.02
P/OCF Ratio	27.36
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.59, with an EV/FCF ratio of 34.05.

EV / Earnings	75.51
EV / Sales	3.77
EV / EBITDA	59.59
EV / EBIT	90.53
EV / FCF	34.05

Financial Position

The company has a current ratio of 5.29, with a Debt / Equity ratio of 0.05.

Current Ratio	5.29
Quick Ratio	3.88
Debt / Equity	0.05
Debt / EBITDA	0.58
Debt / FCF	0.33
Interest Coverage	992.62

Financial Efficiency

Return on equity (ROE) is 6.54% and return on invested capital (ROIC) is 3.23%.

Return on Equity (ROE)	6.54%
Return on Assets (ROA)	2.86%
Return on Invested Capital (ROIC)	3.23%
Return on Capital Employed (ROCE)	5.27%
Revenue Per Employee	603,739
Profits Per Employee	30,478
Employee Count	1,246
Asset Turnover	1.10
Inventory Turnover	1.27

Taxes

In the past 12 months, FRA:2DR has paid 6.36 million in taxes.

Income Tax	6.36M
Effective Tax Rate	14.34%

Stock Price Statistics

The stock price has decreased by -42.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.14%
50-Day Moving Average	70.64
200-Day Moving Average	105.37
Relative Strength Index (RSI)	77.22
Average Volume (20 Days)	10

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.96

Income Statement

In the last 12 months, FRA:2DR had revenue of EUR 752.26 million and earned 37.98 million in profits. Earnings per share was 1.26.

Revenue	752.26M
Gross Profit	638.78M
Operating Income	31.30M
Pretax Income	44.33M
Net Income	37.98M
EBITDA	42.05M
EBIT	31.30M
Earnings Per Share (EPS)	1.26

Balance Sheet

The company has 274.95 million in cash and 27.76 million in debt, giving a net cash position of 247.18 million.

Cash & Cash Equivalents	274.95M
Total Debt	27.76M
Net Cash	247.18M
Net Cash Per Share	n/a
Equity (Book Value)	568.02M
Book Value Per Share	19.55
Working Capital	405.39M

Cash Flow

In the last 12 months, operating cash flow was 113.94 million and capital expenditures -29.72 million, giving a free cash flow of 84.22 million.

Operating Cash Flow	113.94M
Capital Expenditures	-29.72M
Free Cash Flow	84.22M
FCF Per Share	n/a

Margins

Gross margin is 84.92%, with operating and profit margins of 4.16% and 5.05%.

Gross Margin	84.92%
Operating Margin	4.16%
Pretax Margin	5.89%
Profit Margin	5.05%
EBITDA Margin	5.59%
EBIT Margin	4.16%
FCF Margin	11.20%

Dividends & Yields

FRA:2DR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.77%
Shareholder Yield	0.77%
Earnings Yield	1.22%
FCF Yield	2.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:2DR has an Altman Z-Score of 21.04 and a Piotroski F-Score of 6.

Altman Z-Score	21.04
Piotroski F-Score	6